Seeing Is Believing
CRL is currently covered by 12 analysts with an average potential upside of $28.74 (13.38%) from yesterday's end of day stock price of $201.68. Charles River Laboratories International activity chart has currently 141 price targets and 136 ratings on display.
Analysts average stock forecasts to be materialized ratio is 64.25% with an average time for these price targets to be met of 64.36 days.
Highest price target for CRL is $305, Lowest price target is $169, average price target is $237.
Most recent stock forecast was given by RICKY GOLDWASSER from MORGAN STANLEY on 10-Nov-2023. First documented stock forecast 18-Mar-2013.
Currently, out of the existing stock ratings of CRL - 22 which are a Buy (61.11%), 14 which are a Hold (38.89%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
205
$3.32 (1.65%)
220
24 days ago
8/13 (61.54%)
$38 (15.56%)
39
Buy
275
$79.02 (40.32%)
280
2 months 12 days ago
2/6 (33.33%)
$57.96 (28.62%)
88
Buy
256
$54.32 (26.93%)
285
2 months 12 days ago
4/7 (57.14%)
$34.26 (13.93%)
88
Buy
250
$54.02 (27.56%)
275
3 months 24 days ago
1/3 (33.33%)
$47.41 (18.97%)
55
Hold
235
$33.32 (16.52%)
225
3 months 24 days ago
0/2 (0%)
$25.02 (12.48%)
What is CRL (Charles River Laboratories International) average time for price targets to be met?
Which analyst has the current highest performing score on CRL (Charles River Laboratories International) with a proven track record?
Which analyst has the most public recommendations on CRL (Charles River Laboratories International)?
Which analyst is the currently most bullish on CRL (Charles River Laboratories International)?
Which analyst is the currently most reserved on CRL (Charles River Laboratories International)?